The Immune Checkpoint Inhibitors Market is segmented by Inhibitor Type (CTLA-4 Inhibitors, PD-1 Inhibitors, Others), Application (Hodgkin Lymphoma, Kidney Cancers, Melanoma, Non-small Cell Lung Cancer, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region (North America, Europe, Asia-Pacific, and the Rest of the World). This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global market. The historic years considered for the study are 2016-2019, the base year is 2020, and the forecast period is 2021-2026.
What is an immune checkpoint inhibitor?
Immune checkpoint inhibitors may be a style of drug utilized in immunotherapy. Although conventional chemotherapeutic drugs remain the first-line option for the treatment of most cancer types, targeted immune therapies are evolving as standard treatments for advanced-stage cancers. These drugs target cell surface checkpoint proteins to stimulate the popularity and destruction of cancer cells by the system.
Regional Trends
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure and favorable government initiatives. Moreover, rising innovations in technologically advanced products, immense per capita health expenditures; and increasing prevalence of various chronic diseases such as skin cancer, diabetes, urothelial carcinomas, and lung cancers, which further proliferates the regional growth.
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools
More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data
We conducted more than 10 detailed primary interviews with companies across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
